Seenu Kothakota

Dr. Kothakota was recently a leader in the Innovation Group at FivePrime Therapeutics where he worked for 15 years and had an active role in developing the discovery platform. He played a key role in using this platform for the discovery of new therapeutic proteins for cancer, diabetes, and regenerative medicine. He formerly worked at Protein Pathways and as a scientist at Chiron. Dr. Kothakota completed his postdoctoral training with Professor Lewis Williams at the University of California San Francisco, his doctoral work at the University of Massachusetts with Professor Maurille Fournier, and an MBA at Anderson School of Business, UCLA.